In Vitro Activity of Eravacycline in Combination with Colistin Against OXA-type Carbapenemase Producing Klebsiella pneumoniae Isolates

被引:2
|
作者
Ozger, H. Selcuk [1 ]
Cuhadar, Tugba [2 ]
Yildiz, Serap Suzuk [3 ,4 ]
Gulmez, Zehra Demirbas [1 ]
Tunccan, Ozlem Guzel [1 ]
Kalkanci, Ayse [2 ]
Simsek, Husniye [3 ]
Bakkaloglu, Zekiye [4 ]
Dizbay, Murat [1 ]
机构
[1] Gazi Univ, Dept Infect Dis & Clin Microbiol, Sch Med, TR-06560 Ankara, Turkey
[2] Gazi Univ, Dept Clin Microbiol, Sch Med, Ankara, Turkey
[3] Minist Hlth, Gen Directorate Publ Hlth, Natl AMR Surveillance Lab, Ankara, Turkey
[4] Minist Gen Directorate Publ Hlth, Cent Lab, Ankara, Turkey
来源
GAZI MEDICAL JOURNAL | 2021年 / 32卷 / 2A期
关键词
Eravacycline; Colistin; Synergy; Klebsiella pneumoniae; Time-kill assay; RESISTANT ENTEROBACTERIACEAE; ACINETOBACTER-BAUMANNII; SYNERGY; FLUOROCYCLINE; SURVEILLANCE; TIGECYCLINE; EFFICACY; GENES; VIVO;
D O I
10.12996/gmj.2021.64
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: The synergistic activity of eravacycline in combination with colistin on Oxacillinase (OXA) producing carbapenem-resistant Klebsiella pneumoniae isolates (CR-Kp) was evaluated in this study. Methods: Minimum inhibitory concentrations of meropenem were determined by the broth microdilution method. All strains screened for carbapenemase activity by PCR. Chequerboard assay and time-kill analysis were used to assess potential synergy. Results: Synergistic activity was found in 40 % of the strains by chequerboard assay. No antagonism was detected. Comparing to colistin alone at subinhibitory concentrations synergistic and bactericidal activity was observed when it combined with eravacycline. A Similar activity was also observed in colistinresistant CR- Kp isolates. Conclusion: Our results indicate that Eravacycline and colistin combination may be a potential therapeutic option for the treatment of CR- Kp infections.
引用
收藏
页码:276 / 280
页数:5
相关论文
共 50 条
  • [1] Multidrug-resistant Klebsiella pneumoniae clinical isolates producing NDM- and OXA-type carbapenemase in Nepal
    Takei, Satomi
    Tabe, Yoko
    Miida, Takashi
    Hishinuma, Tomomi
    Khasawneh, Abdullah
    Kirikae, Teruo
    Sherchand, Jeevan B.
    Tada, Tatsuya
    JOURNAL OF GLOBAL ANTIMICROBIAL RESISTANCE, 2024, 37 : 233 - 243
  • [2] Synergistic Activity of Colistin/Fosfomycin Combination against Carbapenemase-Producing Klebsiella pneumoniae in an In Vitro Pharmacokinetic/Pharmacodynamic Model
    Wang, Jin
    He, Ji-tong
    Bai, Yan
    Wang, Rui
    Cai, Yun
    BIOMED RESEARCH INTERNATIONAL, 2018, 2018
  • [3] The Combination of Doripenem and Colistin Is Bactericidal and Synergistic against Colistin-Resistant, Carbapenemase-Producing Klebsiella pneumoniae
    Jernigan, Meredith G.
    Press, Ellen G.
    Nguyen, M. Hong
    Clancy, Cornelius J.
    Shields, Ryan K.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2012, 56 (06) : 3395 - 3398
  • [4] In vitro synergistic activity of fosfomycin in combination with meropenem, amikacin and colistin against OXA-48 and/or NDM-producing Klebsiella pneumoniae
    Sengel, Buket Erturk
    Gelmez, Gulsen Altinkanat
    Soyletir, Guner
    Korten, Volkan
    JOURNAL OF CHEMOTHERAPY, 2020, 32 (05) : 237 - 243
  • [5] Heteroresistance to Colistin in Clinical Isolates of Klebsiella pneumoniae Producing OXA-48
    Sanchez-Leon, Irene
    Garcia-Martinez, Teresa
    Diene, Seydina M.
    Perez-Nadales, Elena
    Martinez-Martinez, Luis
    Rolain, Jean-Marc
    ANTIBIOTICS-BASEL, 2023, 12 (07):
  • [6] Epidemiology and in vitro activity of ceftazidime–avibactam, meropenem–vaborbactam, imipenem–relebactam, eravacycline, plazomicin, and comparators against Greek carbapenemase-producing Klebsiella pneumoniae isolates
    Sofia Maraki
    Viktoria Eirini Mavromanolaki
    Eleni Magkafouraki
    Panagiotis Moraitis
    Dimitra Stafylaki
    Anna Kasimati
    Effie Scoulica
    Infection, 2022, 50 : 467 - 474
  • [7] In Vitro Synergism of Azithromycin Combination with Antibiotics against OXA-48-Producing Klebsiella pneumoniae Clinical Isolates
    Singkham-in, Uthaibhorn
    Muhummudaree, Netchanok
    Chatsuwan, Tanittha
    ANTIBIOTICS-BASEL, 2021, 10 (12):
  • [8] The Effects of Colistin on Imipenem MICs in OXA-48 Producing Klebsiella pneumoniae Isolates: An In Vitro Study
    Duman, Yucel
    Tekerekoglu, Mehmet Sait
    Kuzucu, Cigdem
    Yakupogullari, Yusuf
    MEDITERRANEAN JOURNAL OF INFECTION MICROBES AND ANTIMICROBIALS, 2021, 10
  • [9] In vitro evaluation of double carbapenem and colistin combinations against OXA-48, NDM carbapenemase-producing colistin-resistant Klebsiella pneumoniae strains
    Erdem, Fatma
    Abulaila, Ayham
    Aktas, Zerrin
    Oncul, Oral
    ANTIMICROBIAL RESISTANCE AND INFECTION CONTROL, 2020, 9 (01)
  • [10] In vitro evaluation of double carbapenem and colistin combinations against OXA-48, NDM carbapenemase-producing colistin-resistant Klebsiella pneumoniae strains
    Fatma Erdem
    Ayham Abulaila
    Zerrin Aktas
    Oral Oncul
    Antimicrobial Resistance & Infection Control, 9